Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-09-3215
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Downregulation of Vimentin Expression Increased Drug Resistance in Ovarian Cancer Cells

Oncotarget
Oncology
2016English

Exosomes as Mediators of Platinum Resistance in Ovarian Cancer

Oncotarget
Oncology
2017English

Increased Expression of Metallothionein Is Associated With Irinotecan Resistance in Gastric Cancer

Cancer Research
Cancer ResearchOncology
2004English

TCRP1 Expression Is Associated With Platinum Sensitivity in Human Lung and Ovarian Cancer Cells

Oncology Letters
Cancer ResearchOncology
2016English

Is HIPEC Beneficial in Platinum Resistant Relapsed Ovarian Cancer?

Romanian Journal of Medical Practice
2019English

Reduced Expression of P27 Is a Novel Mechanism of Docetaxel Resistance in Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2004English

Annexin A4 Induces Platinum Resistance in a Chloride-And Calcium-Dependent Manner

Oncotarget
Oncology
2014English

Stromal Annexin A2 Expression Is Predictive of Decreased Survival in Pancreatic Cancer

Oncotarget
Oncology
2017English

Reversing Platinum Resistance in Ovarian Cancer Multicellular Spheroids by Targeting BCL-2

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy